The vitamin E-binding protein afamin increases in maternal serum during pregnancy

Clinica Chimica Acta

Volumn 434, Issue , 2014, Pages 41-47

  Hubalek, Michael ^a   Buchner, Hannes ^b   Mörtl, Manfred G ^c   Schlembach, Dietmar ^c,d   Huppertz, Berthold ^c   Firulovic, Branka ^a   Köhler, Wolfgang ^e   Hafner, Erich ^f   Dieplinger, Benjamin ^e   Wildt, Ludwig ^a   Dieplinger, Hans ^a,g  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^f DANUBE HOSPITAL   (Austria)

^g Vitateq Biotechnology GmbH   (Austria)

Author keywords

Afamin in pregnancy; Maternal expression; Preeclampsia; Pregnancy complications

Indexed keywords

AFAMIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; HUMAN PLACENTA LACTOGEN; MESSENGER RNA; UNCLASSIFIED DRUG; VITAMIN BINDING PROTEIN; AFM PROTEIN, HUMAN; ALPHA TOCOPHEROL; CARRIER PROTEIN; GLYCOPROTEIN; SERUM ALBUMIN;

ADULT; AFAMIN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MATERNAL HYPERTENSION; MATERNAL WELFARE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PILOT STUDY; PLACENTA; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PUERPERIUM; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; BLOOD; CLINICAL TRIAL; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; YOUNG ADULT;

ADULT; CARRIER PROTEINS; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HUMANS; PILOT PROJECTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTERS; RETROSPECTIVE STUDIES; SERUM ALBUMIN; VITAMIN E; YOUNG ADULT;

EID: 84899847585     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2014.03.036     Document Type: Article

References (36)

1. Myatt L., Cui X. Oxidative stress in the placenta. Histochem Cell Biol 2004, 122:369-382.
2. Gupta S., Aziz N., Sekhon L., et al. Lipid peroxidation and antioxidant status in preeclampsia: a systematic review. Obstet Gynecol Surv 2009, 64:750-759.
3. Debier C. Vitamin E, during pre- and postnatal periods. Vitam Horm 2007, 76:357-373.
4. Gagne A., Wei S.Q., Fraser W.D., Julien P. Absorption, transport, and bioavailability of vitamin e and its role in pregnant women. J Obstet Gynaecol Can 2009, 31:210-217.
5. Angelucci S., Ciavardelli D., Di Giuseppe F., et al. Proteome analysis of human follicular fluid. Biochim Biophys Acta 2006, 1764:1775-1785.
6. Jerkovic L., Voegele A.F., Chwatal S., et al. Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res 2005, 4:889-899.
7. Voegele A.F., Jerkovic L., Wellenzohn B., et al. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry 2002, 41:14532-14538.
8. Fujimoto V.Y., Kane J.P., Ishida B.Y., Bloom M.S., Browne R.W. High-density lipoprotein metabolism and the human embryo. Hum Reprod Update 2010, 16:20-38.
9. Lichenstein H.S., Lyons D.E., Wurfel M.M., et al. Afamin is a new member of the albumin, α-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem 1994, 269:18149-18154.
10. Dieplinger B., Egger M., Gabriel C., et al. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin Chim Acta 2013, 425:236-241.
11. Braunstein G.D. Endocrine changes in pregnancy. Williams textbook of endocrinology 2007, 741-754. Saunders Elsevier, New York. H.M. Kronenberg, S. Melmed, K.S. Polonsky, P. Reed Larsen (Eds.).
12. Brown M.A., Lindheimer M.D., de Swiet M., Van Assche A., Moutquin J.M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001, 20:IX-XIV.
13. Kratzer I., Bernhart E., Wintersperger A., et al. Afamin is synthesized by cerebrovascular endothelial cells and mediates alpha-tocopherol transport across an in vitro model of the blood-brain barrier. J Neurochem 2009, 108:707-718.
14. Basaran A. Pregnancy-induced hyperlipoproteinemia: review of the literature. Reprod Sci 2009, 16:431-437.
15. Furuhashi N., Tachibana Y., Shinkawa O., Hiruta M., Takahashi T., Tanaka M. Simultaneous and serial measurement of serum levels of human placental lactogen, beta-human chorionic gonadotropin and unconjugated estriol levels in pregnant women. Tohoku J Exp Med 1984, 144:211-215.
16. Markestad T., Bergsjo P., Aakvaag A., et al. Prediction of fetal growth based on maternal serum concentrations of human chorionic gonadotropin, human placental lactogen and estriol. Acta Obstet Gynecol Scand Suppl 1997, 165:50-55.
17. 1-fetoprotein locus. J Biol Chem 1994, 269:5481-5484.
18. Yi H., Xue L., Guo M.X., et al. Gene expression atlas for human embryogenesis. FASEB J 2010, 24:3341-3350.
19. Kobayashi K., Kubota T., Aso T., Hirata Y., Imai T., Marumo F. Immunoreactive adrenomedullin (AM) concentration in maternal plasma during human pregnancy and AM expression in placenta. Eur J Endocrinol 2000, 142:683-687.
20. Senna A.A., Zedan M., el-Salam G.E., el-Mashad A.I. Study of plasma adrenomedullin level in normal pregnancy and preclampsia. Medscape J Med 2008, 10:29.
21. Roberts J.M., Pearson G., Cutler J., Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003, 41:437-445.
22. Steegers E.A., von Dadelszen P., Duvekot J.J., Pijnenborg R. Pre-eclampsia. Lancet 2010, 376:631-644.
23. Akolekar R., Syngelaki A., Sarquis R., Zvanca M., Nicolaides K.H. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks. Prenat Diagn 2011, 31:66-74.
24. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009, 33:130-137.
25. Soleymanlou N., Jurisica I., Nevo O., et al. Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metabol 2005, 90:4299-4308.
26. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008, 51:970-975.
27. Redman C.W., Sargent I.L. Placental stress and pre-eclampsia: a revised view. Placenta 2009, 30(Suppl. A):S38-S42.
28. Rodie V.A., Freeman D.J., Sattar N., Greer I.A. Pre-eclampsia and cardiovascular disease: metabolic syndrome of pregnancy?. Atherosclerosis 2004, 175:189-202.
29. Carty D.M., Delles C., Dominiczak A.F. Novel biomarkers for predicting preeclampsia. Trends Cardiovasc Med 2008, 18:186-194.
30. Giguere Y., Charland M., Bujold E., et al. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem 2010, 56:361-375.
31. Bujold E., Roberge S., Lacasse Y., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010, 116:402-414.
32. Akolekar R., Syngelaki A., Poon L., Wright D., Nicolaides K.H. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013, 33:8-15.
33. Huppertz B., Meiri H., Gizurarson S., Osol G., Sammar M. Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. Hum Reprod Update 2013, 19:391-405.
34. Jackson D., Craven R.A., Hutson R.C., et al. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer. Clin Cancer Res 2007, 13:7370-7379.
35. Melmer A., Fineder L., Lamina C., et al. Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer-a study by the OVCAD consortium. Gynecol Oncol 2013, 128:38-43.
36. Mastricci A.L., Akolekar R., Kuppusamy R., Ahmed M., Nicolaides K.H. Are serum protein biomarkers derived from proteomic analysis useful in screening for trisomy 21 at 11-13 weeks?. Fetal Diagn Ther 2011, 30:53-59.